De Novo Discovery of Pseudo‐Natural Prenylated Macrocyclic Peptide Ligands
Angewandte Chemie International Edition · 2024
DOI: 10.1002/anie.202409973 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2024. Verfasst von Sumika Inoue und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Graduate School of Science, The University of Tokyo, Bunkyo, 113-0033, Tokyo, Japan. Hauptthemen laut MEDLINE: Prenylation. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Prenylation of peptides is widely observed in the secondary metabolites of diverse organisms, granting peptides unique chemical properties distinct from proteinogenic amino acids. Discovery of prenylated peptide agents has largely relied on isolation or genome mining of naturally occurring molecules. To devise a platform technology for de novo discovery of artificial prenylated peptides targeting a protein of choice, here we have integrated the thioether‐macrocyclic peptide (teMP) library construction/selection technology, so‐called RaPID (Random nonstandard Peptides Integrated Discovery) system, with a Trp‐ C3‐ prenyltransferase KgpF involved in the biosynthesis of a prenylated natural product. This unique enzyme exhibited remarkably broad substrate tolerance, capable of modifying various Trp‐containing teMPs to install a prenylated residue with tricyclic constrained structure. We constructed a vast library of prenylated teMPs and subjected it to in vitro selection against a phosphoglycerate mutase. This selection platform has led to the identification of a pseudo‐natural prenylated teMP inhibiting the target enzyme with an IC 50 of 30 nM. Importantly, the prenylation was essential for the inhibitory activity, enhanced serum stability, and cellular uptake of the peptide, highlighting the benefits of peptide prenylation. This work showcases the de novo discovery platform for pseudo‐natural prenylated peptides, which is readily applicable to other drug targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Graduate School of Science, The University of Tokyo, Bunkyo, 113-0033, Tokyo, Japan.
- Department of Biochemistry, Graduate School of Medicine, Yokohama City University, Kanazawa-ku, 236-0004, Yokohama, Japan.
- Department of Material and Life Chemistry, Kanagawa University, Kanagawa-ku, 221-8686, Yokohama, Japan.
- Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo, 113-0033, Tokyo, Japan.
- Department of Chemistry, Graduate School of Science, Kyoto University, Sakyo, 606-8502, Kyoto, Japan.
- Toyota Riken Rising Fellow, Toyota Physical and Chemical Research Institute, Sakyo, 606-8502, Kyoto, Japan.
ORCID-Profile: Yuki Goto, Hiroaki Suga
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Inoue, S., Thanh Nguyen, D., Hamada, K., Okuma, R., Okada, C., Okada, M., Abe, I., Sengoku, T., Goto, Y., & Suga, H. (2024). De Novo Discovery of Pseudo‐Natural Prenylated Macrocyclic Peptide Ligands. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202409973
Vancouver
Inoue S, Thanh Nguyen D, Hamada K, Okuma R, Okada C, Okada M, et al. De Novo Discovery of Pseudo‐Natural Prenylated Macrocyclic Peptide Ligands. Angewandte Chemie International Edition. 2024. doi:10.1002/anie.202409973
BibTeX
@article{Inoue2024,
author = {Inoue, Sumika and Thanh Nguyen, Dinh and Hamada, Keisuke and Okuma, Rika and Okada, Chikako and Okada, Masahiro and Abe, Ikuro and Sengoku, Toru and Goto, Yuki and Suga, Hiroaki},
title = {De Novo Discovery of Pseudo‐Natural Prenylated Macrocyclic Peptide Ligands},
journal = {Angewandte Chemie International Edition},
year = {2024},
doi = {10.1002/anie.202409973}
}
EUVIMED